Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients

被引：0
|
作者：
Elisabetta Venturelli
Annalisa Orenti
Aline S. C. Fabricio
Giulia Garrone
Roberto Agresti
Biagio Paolini
Chiara Bonini
Massimo Gion
Franco Berrino
Christine Desmedt
Danila Coradini
Elia Biganzoli
机构：
[1] Department of Research,Department of Diagnostic Pathology and Laboratory
[2] Fondazione IRCCS Istituto Nazionale dei Tumori,Breast Cancer Translational Research Laboratory, J. C. Heuson, Institut Jules Bordet
[3] Laboratory of Medical Statistics and Epidemiology,Unit of Medical Statistics, Biometry and Bioinformatics
[4] “Giulio A. Maccacaro”,undefined
[5] Department of Clinical Sciences and Community Health,undefined
[6] Regional Center for Biomarkers,undefined
[7] Department of Clinical Pathology and Transfusion Medicine,undefined
[8] Breast Surgery Unit,undefined
[9] Fondazione IRCCS Istituto Nazionale dei Tumori,undefined
[10] Fondazione IRCCS Istituto Nazionale dei Tumori,undefined
[11] Université Libre de Bruxelles,undefined
[12] Campus Cascina Rosa,undefined
[13] Fondazione IRCCS Istituto Nazionale Tumori,undefined
来源：
BMC Cancer | / 18卷
关键词：
Testosterone; Body mass index; Estrogen receptor; Postmenopausal women; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] THE PROGNOSTIC VALUE OF ESTROGEN-RECEPTOR DETERMINATIONS IN PATIENTS WITH PRIMARY BREAST-CANCER - AN UPDATE
    FURMANSKI, P
    SAUNDERS, DE
    BROOKS, SC
    RICH, MA
    CANCER, 1980, 46 (12) : 2794 - 2796
  • [32] Impact of increased adiposity on extended aromatase inhibitor treatment in postmenopausal patients with estrogen receptor positive (ER plus ) breast cancer: a retrospective analysis of the SOLE trial
    Isnaldi, Edoardo
    Richard, Francois
    Marano, Giuseppe
    Boracchi, Patrizia
    Maetens, Marion
    Floris, Giuseppe
    Jerusalem, Guy
    Gombos, Andrea
    Thompson, Alastair M.
    Stefan, Erika Hitre
    Colleoni, Marco
    Dell'Orto, Patrizia
    Kammler, Roswitha
    Neven, Patrick
    Viale, Giuseppe
    Regan, Meredith
    Biganzoli, Elia
    Desmedt, Christine
    CANCER RESEARCH, 2023, 83 (05)
  • [33] Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM Trial
    Bartlett, John M. S.
    Xu, Keying
    Wong, Jenna
    Pond, Gregory
    Zhang, Yi
    Spears, Melanie
    Salunga, Ranelle
    Mallon, Elizabeth
    Taylor, Karen J.
    Hasenburg, Annette
    Markopoulos, Christos
    Dirix, Luc
    van de Velde, Cornelis J. H.
    Rea, Daniel
    Schnabel, Catherine A.
    Treuner, Kai
    Bayani, Jane
    CLINICAL CANCER RESEARCH, 2024, 30 (08) : 1509 - 1517
  • [34] Prognostic Value of Estrogen Receptor α and Progesterone Receptor Conversion in Distant Breast Cancer Metastases
    Hoefnagel, Laurien D. C.
    Moelans, Cathy B.
    Meijer, S. L.
    van Slooten, Henk-Jan
    Wesseling, Pieter
    Wesseling, Jelle
    Westenend, Pieter J.
    Bart, Joost
    Seldenrijk, Cornelis A.
    Nagtegaal, Iris D.
    Oudejans, Joost
    van der Valk, Paul
    van Gils, Carla H.
    van der Wall, Elsken
    van Diest, Paul J.
    CANCER, 2012, 118 (20) : 4929 - 4935
  • [35] Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor-Positive and -Negative Cancers
    Bianchini, Giampaolo
    Qi, Yuan
    Alvarez, Ricardo H.
    Iwamoto, Takayuki
    Coutant, Charles
    Ibrahim, Nuhad K.
    Valero, Vicente
    Cristofanilli, Massimo
    Green, Marjorie C.
    Radvanyi, Laszlo
    Hatzis, Christos
    Hortobagyi, Gabriel N.
    Andre, Fabrice
    Gianni, Luca
    Symmans, W. Fraser
    Pusztai, Lajos
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (28) : 4316 - 4323
  • [36] Prognostic and Predictive Biomarkers of Endocrine Responsiveness for Estrogen Receptor Positive Breast Cancer
    Ma, Cynthia X.
    Bose, Ron
    Ellis, Matthew J.
    NOVEL BIOMARKERS IN THE CONTINUUM OF BREAST CANCER, 2016, 882 : 125 - 154
  • [37] Scattered fat invasion: An indicator for poor prognosis in premenopausal, and for positive estrogen receptor in postmenopausal breast cancer patients
    Kimijima, I
    Ohtake, T
    Sagara, H
    Watanabe, T
    Takenoshita, S
    ONCOLOGY, 2000, 59 : 25 - 30
  • [38] Adjuvant therapy with aromatase inhibitors in postmenopausal, estrogen receptor-positive breast cancer patients: upfront or sequential?
    Dediu, M.
    Median, D.
    Alexandru, A.
    Vremes, G.
    Gal, C.
    Gongu, M.
    JOURNAL OF BUON, 2009, 14 (03): : 375 - 379
  • [39] KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients
    Kammerer, Sarah
    Sokolowski, Armin
    Hackl, Hubert
    Platzer, Dieter
    Jahn, Stephan Wenzel
    El-Heliebi, Amin
    Schwarzenbacher, Daniela
    Stiegelbauer, Verena
    Pichler, Martin
    Rezania, Simin
    Fiegl, Heidelinde
    Peintinger, Florentia
    Regitnig, Peter
    Hoefler, Gerald
    Schreibmayer, Wolfgang
    Bauernhofer, Thomas
    ONCOTARGET, 2016, 7 (51): : 84705 - 84717
  • [40] HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
    Batra, Atul
    Kumar, Akash
    BREAST, 2021, 55 : 136 - 136
12345